Adjuvant hormone therapy in breast carcinoma
Schneider, G.
Deutsche Medizinische Wochenschrift 118(25): 961-962
1993
ISSN/ISBN: 0012-0472 PMID: 8519222 Document Number: 421989
Document emailed within 1 workday
Related Documents
Senn, H.J. 1987: Current status of adjuvant chemo- and hormone therapy in resectable breast carcinoma Schweizerische Rundschau für Medizin Praxis 76(43): 1193-1199Boccardo, F.; Valenti, G.; De Menech, R.; Zanardi, S. 1986: Adjuvant hormone therapy of breast neoplasms. A critical review of the literature and perspectives Minerva Ginecologica 38(7-8): 659-665
Semiglazov, V.F.; Moiseenko, V.M.; Ivanova, O.A. 1986: Prospective randomized study of the efficacy of adjuvant hormone therapy in patients with breast cancer Voprosy Onkologii 32(8): 31-34
Uhlenbruck, G.; VAN Leendert, R.; Schneider, B.; Beuth, J. 2010: Reduced side-effects of adjuvant hormone therapy in breast cancer patients by complementary medicine In Vivo 24(5): 799-802
Abe, R.; Tsuchiya, A.; Koie, H.; Ono, K.; Abo, S.; Saito, K.; Tsukamoto, M.; Sato, T.; Mori, S.; Motoki, R. 1988: Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 15(9): 2707-2712
Cleton, F.J.; Engelsman, E.; Nooy, M. 1986: Adjuvant therapy in patients with operable breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 130(16): 719-721
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Fey, M.F.; Castiglione-Gertsch, M. 1996: Questions and answers on adjuvant systemic therapy in breast carcinoma Therapeutische Umschau. Revue Therapeutique 53(11): 839-846
Margolis, D.S.; McMillen, M.A.; Hashmi, H.; Wasson, D.W.; MacArthur, J.D. 1992: Aggressive axillary evaluation and adjuvant therapy for nonpalpable carcinoma of the breast Surgery Gynecology and Obstetrics 174(2): 109-113
Fazio, M.; Calabrese, F.; Giacomasso, S.; Mastromatteo, V.; Negri, L. 1988: Adjuvant therapy in breast carcinoma. a specific immunologic preliminary contribution Minerva Chirurgica 43(18 Suppl): 59-62
Goldhirsch, A.; Neuenschwander, H.; Castiglione, M.; Senn, H.J.; Cavalli, F. 1990: Adjuvant systemic therapy in breast carcinoma in the 1990s: status of things and open questions Schweizerische Medizinische Wochenschrift 120(47): 1771-1783
Bardi, M.; Arnoldi, E.; Pizzocchero, G.; Pezzica, E.; Mattioni, D.; Perotti, M. 1994: Endometrioid carcinoma in pelvic endometriosis in a postmenopausal woman with tamoxifen adjuvant therapy for breast cancer. A case report European Journal of Gynaecological Oncology 15(5): 393-395
Fazio, M.; Cavallero, P.; Rattalino, G.; Sartoris, S.; Vergnano, F. 1976: Combination drug-hormone therapy of the advanced stages of breast carcinoma Minerva Ginecologica 28(7-8): 623-629
Rahko, E.; Jukkola, A.; Melkko, J.; Paavo, P.ääk.ö; Bloigu, R.; Talvensaari-Mattila, A.; Turpeenniemi-Hujanen, T. 2004: Matrix metalloproteinase-9 (MMP-9) immunoreactive protein has modest prognostic value in locally advanced breast carcinoma patients treated with an adjuvant antiestrogen therapy Anticancer Research 24(6): 4247-4253
Petru, E.; Beck, K.; Schünemann, H.; Schmähl, D. 1991: The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma Wiener Medizinische Wochenschrift 141(7): 133-135
Yoshida, M.; Saji, S.; Takagi, H.; Takeuchi, S.; Tsuda, H.; Nimura, Y.; Mizumoto, R.; Miyazaki, I.; Kobayashi, S.; Noguchi, M. 1993: A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. the Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(15): 2325-2333
Di Vito, F.; Grasso, F.; Salvi, F. 1985: Applicability to clinical practice of prospective studies of adjuvant medical therapy in surgically treated breast carcinoma. Clinical contribution Minerva Ginecologica 37(6): 333-334
Sutepvarnon, A.; Warnnissorn, M.; Srimuninnimit, V. 2013: Predictive value of Ki67 for adjuvant chemotherapy in node-negative, hormone receptor-positive breast cancer Journal of the Medical Association of Thailand 96(Suppl 2): S60-S66
Seegenschmiedt, M.H.; Sauer, R.; Strnad, V. 1995: Adjuvant radiotherapy of breast carcinoma Praxis 84(13): 377-385
Bruning, P.F.; Bartelink, H.; van Dongen, J.A.; Peterse, J.L. 1993: Adjuvant treatment of breast carcinoma Nederlands Tijdschrift Voor Geneeskunde 137(46): 2364-2370